Home/Filings/4/0001724521-25-000089
4//SEC Filing

Ribas Antoni 4

Accession 0001724521-25-000089

CIK 0001724521other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 4:28 PM ET

Size

18.1 KB

Accession

0001724521-25-000089

Insider Transaction Report

Form 4
Period: 2025-06-10
Ribas Antoni
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-10+38,30038,300 total
    Exercise: $10.02Exp: 2035-06-09Common Stock (38,300 underlying)
  • Award

    Common Stock

    2025-06-10+13,30043,650 total
Holdings
  • Common Stock

    (indirect: By Trust)
    8,553
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
  • [F2]The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001792164

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:28 PM ET
Size
18.1 KB